Latest scientific publications

  • Targeted serum metabolomic profiling and machine learning approach in Alzheimer's disease using the Alzheimer's disease diagnostics clinical study (ADDIA) cohort.

  • Auteurs Mukesha D, Sarter M, Dubray M, Durand F, Boutillier S, Pham-Van LD, Halter D, Kul S, Blanc F, Gürvit H, Demiralp T, Dubois B, Gabelle A, Marizzoni M, Frisoni GB, Pasquier F, Sellal F, Ivanoiu A, Bier JC, David R, Démonet JF, Magnin E, Sacco G, Firat H
  • Revue J Alzheimers Dis
  • Date de publication 2025-09
Targeted serum metabolomic profiling and machine learning approach in Alzheimer's disease using the Alzheimer's disease diagnostics clinical study (ADDIA) cohort.
  • RPE65 Variant p.(E519K) Causes a Novel Dominant Adult-Onset Maculopathy in 83 Affected Individuals.

  • Auteurs Van Vooren E, Van Den Broeck F, Mahieu Q, Geens E, Van Heetvelde M, De Bruyne M, Van de Sompele S, Uppal S, Poliakov E, Dhaenens CM, Gregory-Evans CY, Hoefsloot L, Gonzalez AI, Kohl S, Zuleger T, Demaret T, Tuupanen S, Ruys J, Van Os L, Platteau E, Jacob J, Vermeer S, Postelmans L, Dahan K, Maystadt I, Rasquin F, Thiadens AAHJ, Stephenson KAJ, Sheri N, Smirnov V, MacDonald IM, Gregory-Evans K, Redmond TM, De Zaeytijd J, Leroy BP, Bauwens M, De Baere E
  • Revue Invest Ophthalmol Vis Sci
  • Date de publication 2025-09
RPE65 Variant p.(E519K) Causes a Novel Dominant Adult-Onset Maculopathy in 83 Affected Individuals.
  • Assessing the oncologic risk when systematic and multiparametric magnetic resonance imaging-targeted prostate biopsy grade groups are discordant.

  • Auteurs Scuderi S, Tin AL, Marra G, Bianchi L, Kesch C, Soeterik TFW, Ploussard G, Zattoni F, Ettala O, Røder A, Poyet C, Stroomberg HV, Cimmino U, Fiard G, Nordström T, Patel HD, Gupta GN, Yonover PM, Guillaume B, Gaffney C, Zhuang J, Wang Y, Sarkis J, Jabbour T, Diamand R, Windisch O, Olivier J, Abbadi A, Kim EH, Wang JC, Hu J, Zhu A, Stabile A, Eastham JA, Montorsi F, Briganti A, Gandaglia G, Vickers AJ
  • Revue J Natl Cancer Inst
  • Date de publication 2025-09
Assessing the oncologic risk when systematic and multiparametric magnetic resonance imaging-targeted prostate biopsy grade groups are discordant.
Bordet hospital

Jules Bordet Institute

View all of Jules Bordet's scientific publications

Erasme hospital

Erasme Hospital

View all of Erasme's scientific publications

Huderf hospital

Queen Fabiola Children's Hospital

View all scientific publications from the Queen Fabiola Children's Hospital